home > bioproject > PRJDB5053
identifier PRJDB5053
type bioproject
sameAs
organism Homo sapiens
title Effect of a poly(ADP-ribose) polymerase-1 inhibitor against esophageal squamous cell carcinoma cell lines
description Effective molecular target drugs that improve therapeutic efficacy with fewer adverse effects for esophageal cancer are highly anticipated. Poly(ADP-ribose) polymerase (PARP) inhibitors have been proposed as low-toxicity agents to treat double strand break (DSB)-repair defective tumors. Several findings imply the potential relevance of DSB repair defects in the tumorigenesis of esophageal squamous cell carcinoma (ESCC). We evaluated the effect of a PARP Inhibitor (AZD2281) on the TE-series ESCC cell lines.
data type Exome
publication
10.1111/cas.12322
properties 
{...}
dbXrefs
sra-run  DRR066523DRR066524
sra-submission  DRA004931
biosample  SAMD00056738SAMD00056739
sra-study  DRP004356
sra-sample  DRS071856DRS071857
sra-experiment  DRX060486DRX060487
distribution JSONJSON-LD
Download
ddbj_core_bioproject.xml  HTTPS FTP
status public
visibility unrestricted-access
dateCreated 2016-07-29T08:59:39+09:00
dateModified 2018-07-29T13:01:52+09:00
datePublished 2018-07-29T13:01:51+09:00